Few tests cause as much anxiety as the PSA. The result arrives with a number above the reference range, and the immediate reading is almost always the same: cancer. In everyday practice at the clinic, that premature conclusion tends to be the start of weeks of unnecessary suffering.

PSA is a protein produced by the prostate, not by cancer. It can rise in a number of situations, many of them benign. That is why a single value defines nothing on its own: it has to be interpreted together with your history, the clinical exam and, when indicated, imaging studies.

What can raise PSA besides cancer

  • Benign prostatic hyperplasia: the benign growth of the prostate, common as men get older, increases the production of the protein.
  • Prostatitis and urinary infections: inflammatory processes can raise the value considerably, sometimes only temporarily.
  • Recent manipulation of the prostate: exams, urinary catheterization and procedures can interfere with the result.
  • Ejaculation and intense physical activity: recent sexual activity or a long bike ride before the blood draw can alter the measurement.
  • Urinary retention: difficulty emptying the bladder also has an influence.

That is why, when a value comes back elevated for the first time, the most sensible next step is often not to schedule a biopsy, but to repeat the test under proper conditions and look at the whole picture.

The number matters less than the context

In a urological assessment, PSA is read within a larger picture. Your age, the size of the prostate, family history, how the test behaves over time and the clinical exam all carry weight in the decision. A value that stays stable for years tells a different story from one that rises consistently.

An abnormal test is not a sentence. It is an invitation to investigate methodically.

The next steps when the investigation continues

Clinical assessment

The consultation sets the direction. Urinary symptoms, associated conditions, current medications and family history change how the test is interpreted and how urgent the situation is.

Multiparametric MRI

When there is suspicion, prostate MRI helps identify suspicious areas and classify them. It makes it possible to decide with more confidence whether a biopsy is needed and, when it is, it shows exactly where to sample the tissue.

Targeted biopsy

The biopsy is the test that confirms or rules out the diagnosis. Today it can be directed at the suspicious areas identified on imaging, which makes sampling more accurate than sampling done blindly.

And if the diagnosis is confirmed

Even with a confirmed diagnosis, there is more than one path. Low-risk tumors, in selected patients, can be followed closely with active surveillance and periodic testing, without immediate surgery. Other cases call for treatment, which may include surgery or radiation therapy, always alongside a discussion about controlling the disease and preserving quality of life.

The central point is the same in every situation: the decision has to be individual, made with clear information and without unnecessary haste.

Important: this content is for informational purposes and does not replace a medical consultation. Each case needs to be assessed individually by a qualified professional.